ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 101 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2014. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $552,316 | -42.2% | 15,493 | -25.2% | 0.00% | – |
| Q2 2023 | $955,799 | -59.3% | 20,720 | -64.6% | 0.00% | -100.0% |
| Q1 2023 | $2,345,650 | +32.6% | 58,495 | +53.2% | 0.00% | 0.0% |
| Q4 2022 | $1,769,000 | +165.2% | 38,183 | +137.3% | 0.00% | – |
| Q3 2022 | $667,000 | -23.3% | 16,091 | +10.3% | 0.00% | – |
| Q2 2022 | $870,000 | -17.8% | 14,583 | +0.1% | 0.00% | – |
| Q1 2022 | $1,058,000 | -15.7% | 14,573 | -2.3% | 0.00% | – |
| Q4 2021 | $1,255,000 | -5.4% | 14,919 | +1.5% | 0.00% | – |
| Q3 2021 | $1,326,000 | -44.5% | 14,695 | -41.4% | 0.00% | -100.0% |
| Q2 2021 | $2,391,000 | -13.2% | 25,060 | +3.5% | 0.00% | 0.0% |
| Q1 2021 | $2,755,000 | -51.4% | 24,212 | -40.8% | 0.00% | -50.0% |
| Q4 2020 | $5,666,000 | +197.3% | 40,926 | +76.4% | 0.00% | +100.0% |
| Q3 2020 | $1,906,000 | +24.0% | 23,196 | +17.9% | 0.00% | 0.0% |
| Q2 2020 | $1,537,000 | +32.8% | 19,667 | -24.6% | 0.00% | 0.0% |
| Q1 2020 | $1,157,000 | +187.8% | 26,087 | +176.0% | 0.00% | – |
| Q4 2019 | $402,000 | -99.0% | 9,452 | -99.0% | 0.00% | -100.0% |
| Q3 2019 | $38,580,000 | -33.8% | 901,828 | -1.7% | 0.02% | -34.6% |
| Q2 2019 | $58,269,000 | +1.5% | 917,625 | +10.9% | 0.03% | 0.0% |
| Q1 2019 | $57,412,000 | +56.0% | 827,760 | -2.2% | 0.03% | +44.4% |
| Q4 2018 | $36,806,000 | -60.9% | 846,472 | -31.3% | 0.02% | -45.5% |
| Q3 2018 | $94,071,000 | -8.1% | 1,232,273 | -7.4% | 0.03% | -26.7% |
| Q2 2018 | $102,348,000 | +67.4% | 1,331,462 | +11.0% | 0.04% | +60.7% |
| Q1 2018 | $61,137,000 | +3458.6% | 1,199,031 | +3136.6% | 0.03% | +2700.0% |
| Q4 2017 | $1,718,000 | -30.7% | 37,046 | -20.4% | 0.00% | 0.0% |
| Q3 2017 | $2,479,000 | -60.8% | 46,563 | -54.2% | 0.00% | -66.7% |
| Q2 2017 | $6,320,000 | -1.4% | 101,774 | +7.6% | 0.00% | 0.0% |
| Q1 2017 | $6,407,000 | -15.7% | 94,545 | -12.5% | 0.00% | -25.0% |
| Q4 2016 | $7,600,000 | -38.4% | 108,111 | -37.8% | 0.00% | -42.9% |
| Q3 2016 | $12,335,000 | -27.8% | 173,819 | -50.2% | 0.01% | -30.0% |
| Q2 2016 | $17,085,000 | +28.7% | 349,253 | +66.5% | 0.01% | +25.0% |
| Q1 2016 | $13,279,000 | -74.8% | 209,742 | -55.4% | 0.01% | -74.2% |
| Q4 2015 | $52,762,000 | +45.3% | 470,334 | +24.8% | 0.03% | +40.9% |
| Q3 2015 | $36,307,000 | +215.2% | 376,954 | +235.1% | 0.02% | +214.3% |
| Q2 2015 | $11,517,000 | +268.7% | 112,497 | +123.7% | 0.01% | +250.0% |
| Q1 2015 | $3,124,000 | +187.7% | 50,300 | +103.2% | 0.00% | +100.0% |
| Q4 2014 | $1,086,000 | -58.5% | 24,754 | -46.5% | 0.00% | -50.0% |
| Q3 2014 | $2,620,000 | -47.4% | 46,301 | -58.3% | 0.00% | -33.3% |
| Q2 2014 | $4,983,000 | -36.5% | 110,990 | -30.9% | 0.00% | -40.0% |
| Q1 2014 | $7,850,000 | – | 160,533 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |